Stay updated on Anti-PD-1 and DC-CIK in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Anti-PD-1 and DC-CIK in Solid Tumors Clinical Trial page.
Latest updates to the Anti-PD-1 and DC-CIK in Solid Tumors Clinical Trial page
- Check3 days agoChange DetectedThe page shows a minor site revision label updated from Revision: v3.3.3 to v3.3.4 in the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedNew location added: Beijing Municipality (Beijing, Capital Medical University Cancer Center/Beijing Shijitan Hospital). The page revision is updated to v3.3.3, and the HHS Vulnerability Disclosure link as well as the previous Beijing Municipality Locations entry (v3.3.2) were removed.SummaryDifference0.3%
- Check53 days agoChange DetectedPage revision label updated from v3.2.0 to v3.3.2. No changes to the study details or content were observed.SummaryDifference0.1%
- Check60 days agoChange DetectedThe government funding lapse notice was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check74 days agoChange DetectedThe new screenshots show minor UI updates and small text edits while the core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%
- Check103 days agoChange DetectedMajor update: operating-status notice and new version v3.2.0; old v3.1.0 reference removed.SummaryDifference4%
Stay in the know with updates to Anti-PD-1 and DC-CIK in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-PD-1 and DC-CIK in Solid Tumors Clinical Trial page.